Boundless Bio, which is developing treatments focusing on extrachromosomal DNA, has raised $46.4m from investors including Alexandria Venture Investments.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

SE Health featured in an oversubscribed round telemedicine provider Maple announced alongside an investment by Royal Bank of Canada, the deals totalling $14.5m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Triventures, which already has several corporate backers, has raised more than half of the capital for a $40m fund it has launched with Chaim Sheba Medical Center.

Alexandria LaunchLabs will launch in early 2021 as Stanford University looks to bolster its life sciences ecosystem and provide more flexible workspace options for its researchers.

University of Cambridge-founded autoimmune disease developer PredictImmune has expanded its IP base with first refusal rights on prognostics for systemic lupus erythematosus.

Tencent was among the investors in a series B round that will help AllinMD expand its orthopaedic training and care access platform as well as its hospitals.

The Lundbeck and Upsher-Smith-backed drug development technology provider reportedly raised the funding at half the $2bn valuation of its last round in 2018.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.